Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RiaSTAP vs Cryoprecipitate to Lower Operative Transfusions
NCT02540434Terminated
- Sponsor
- Weill Cornell Medicine
- Start
- Oct 2015
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of Fibrinogen human in hypofibrinogenemia and coagulopathy, sponsored by Weill Cornell Medicine. Primary endpoint: Intraoperative Blood Transfusion Total at 6 hours. Started Oct 2015; status: terminated.
02
Drugs
Fibrinogen human
03
Conditions
hypofibrinogenemiacoagulopathy
Beyond the preview
Go deeper on NCT02540434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02540434.